Liposomal MTP-PE for the adjuvant therapy of osteosarcoma

Prog Clin Biol Res. 1990:343:263-79.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylmuramyl-Alanyl-Isoglutamine / administration & dosage
  • Acetylmuramyl-Alanyl-Isoglutamine / analogs & derivatives*
  • Adjuvants, Immunologic / administration & dosage
  • Animals
  • Antineoplastic Agents / therapeutic use
  • Biotechnology
  • Child
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dogs
  • Drug Carriers
  • Humans
  • Immunotherapy
  • Liposomes
  • Monocytes / immunology
  • Osteosarcoma / secondary
  • Osteosarcoma / therapy*
  • Phosphatidylethanolamines / administration & dosage*

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes
  • Phosphatidylethanolamines
  • mifamurtide
  • Acetylmuramyl-Alanyl-Isoglutamine